http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
최창락,안명수 대한신경외과학회 1983 Journal of Korean neurosurgical society Vol.12 No.4
Our experienced is based on a series of 5 cases of dystonia who underwent stereotaxic thalamotomy. The immediate good results have been obtained by thalamotomy. We have been able to estimate secondary deterioration on long term results in patients examined 2-5 years postoperatively. Some deterioration is noted patients operated on for athetosis over the age of 20. A pallido-subthalamic lesion is efficient at the beginning of the disease course since it improves motor performance and thereby helps possiblities of intellectual acquirement. Bilateral lesions have done after improved I.Q. Effects of this treatment specially on spasticity must be discussed among other types of surgery.
조경근,이일우,조태훈,김문찬,강준기,송진언 대한신경외과학회 1987 Journal of Korean neurosurgical society Vol.16 No.2
According to the general principle that a surgical procedure should be as atraumatic as possible, several authors proposed stereotaxic urokinase treatment in spontaneous intraoerebral hematomas. Authors presented 29 cases of spontaneous intracerebral hematomas which were managed wit stereotaxic urokinase treatment including 10 cases of preliminary report on Journal of Korean Neurosurgical Society June 1986. 19 cases were basal ganglia hematomas with or without ventricular rupture, 4 cases were thalamic hematomas with ventricular rupture, 3 cases were subcortical hematomas and 3 eases were intraventricular hematomas. The outcome of the treatment was analysed by the location and amount of hematomas, and the degree of disability of patient on admission and discharge. The outcome was worst in thalamic hematoms than putaminal or subcortical hematomas, and poorer as the amount of hem atom a increased. The outcome was bad also in the patient who showed poor neurologic condition on admission. Time requiring hematoma dissapperance with urokinase treatment was estimated by the short term follow up CT scanning. All of the patient except moribund cases showed complete dissappearance of hematomas within 10 days after treatment, and mean period was 6.7 days. Rebleeding after the urokinase treatment was noted in 4 cases, which was 2 putaminal, one thalamic and one ventricular hematoma. The cause of rebleeding might be mechanical injury of catheter insertion or too strong negative pressure on aspiration. But in 1 case of intraventricular hematoma, the possible causative factor should be anticoagulant effect of urokinase on the injured vessel. With above result, we concluded that this procedure may be better and safer than conventional craniotomy especially in cases of high risky or elderly patient with deep seated intracerebral hematomas. But the efficacy and safety must be studied further with the exact experimental model of spontaneous intracerebral hematomas.
Urokinase의 뇌정위적 혈종내 주입에 의한 자발성 두개강내 혈종의 치료 효과
박춘근,정철구,백민우,김문찬,김달수,하영수,강준기,송진언 대한신경외과학회 1985 Journal of Korean neurosurgical society Vol.14 No.2
Authors describe methods for evacuation of intracerebral and/or intrventricular hematomas with CT-aided stereotaxic infusion of urokinase into the hematoma and controlled drainage. In the past 6 months we performed the procedures in 21 cases during acute (within 3 days) or subacute (between 4 and 14 days) stage after the apoplectic attack. Three dimensional CT images were used to locate the hematoma sites, to assess its volume and to determine stereotaxic coordinates. Under local anesthesia a silicon tube was inserted into the hematoma through a burr hole and the hematoma was aspirated with syringe. And then urokinase (6,000 IU/5㎖ saline) was infused into the hematoma and the drain was clipped. Thereafter aspiration and administration were performed repeatedly every 6 hours until the hematoma was completely removed. In cases of intraventricular hematoma a drain was inserted into the ventricle having the main hematoma. As a first trial of hematoma removal, the ventricle was irrigated with urokinase (6,000 IU/100㎖ saline), and the drain was clipped after administration of urokinase (6,000 IU/5㎖ saline). Subequentry clipping of the drain for 4 hours and drainage of the CSF with the hematoma for 2 hours were repeated under the monitoring of intracranial pressure. Now we review serial changes of CT findings and results of 10 cases which were followed up for at least 4 months' and priliminarily conclude that this procedure may be as good as conventional cranitomy, and safer and less traumatic than any other management especially in cases of intraventricular or deep seated hematomas and elderly or high-risk patients.